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Spontaneous Bacterial Keratitis in CD36 Knockout Mice
Julia Klocke,1 Rita N. Barcia,1 Susan Heimer,1 Elke Cario,2 James Zieske,1
Michael S. Gilmore,1 Bruce R. Ksander,1 and Meredith S. Gregory1
PURPOSE. CD36 is a Class B scavenger receptor that is constitu-
tively expressed in the corneal epithelium and has been impli-
cated in many homeostatic functions, including the homeosta-
sis of the epidermal barrier. The aim of this study is to
determine (1) whether CD36 is required for the maintenance
of the corneal epithelial barrier to infection, and (2) whether
CD36-deficient mice present with an increased susceptibility to
bacterial keratitis.
METHODS. The corneas of CD36/, TSP1/, TLR2/, and
C57BL/6 WT mice were screened via slit lamp microscopy or
ex vivo analysis. The epithelial tight junctions and mucin layer
were assessed via LC-biotin and Rose Bengal staining, respec-
tively. Bacterial quantification was performed on corneal but-
tons and GFP-expressing Staphylococcus aureus was used to
study bacterial binding.
RESULTS. CD36/ mice develop spontaneous corneal defects
that increased in frequency and severity with age. The mild
corneal defects were characterized by a disruption in epithelial
tight junctions and the mucin layer, an infiltrate of macro-
phages, and increased bacterial binding. Bacterial quantifica-
tion revealed high levels of Staphylococcus xylosus in the
corneas of CD36/ mice with severe defects, but not in
wild-type controls.
CONCLUSIONS. CD36/ mice develop spontaneous bacterial
keratitis independent of TLR2 and TSP1. The authors conclude
that CD36 is a critical component of the corneal epithelial
barrier, and in the absence of CD36 the barrier breaks down,
allowing bacteria to bind to the corneal epithelium and result-
ing in spontaneous keratitis. This is the first report of sponta-
neous bacterial keratitis in mice. (Invest Ophthalmol Vis Sci.
2011;52:256–263) DOI:10.1167/iovs.10-5566
Although Staphylococci are found in the normal flora of theocular surface, mice are highly resistant to infection and
do not develop spontaneous bacterial keratitis. Resistance to a
corneal infection is dependent on the presence of multiple
barriers that prevent bacterial adhesion and invasion. The dis-
ruption of any one of these barriers increases significantly the
susceptibility to infection. Two of the critical barriers are the
mucin layer, which prevents bacterial binding to the cornea,
and the intercellular tight junctions of the corneal epithelium,
which prevent bacterial penetration into the cornea.1,2 In the
normal cornea, these barriers effectively prevent infection.
However, a disruption of these barriers due to injury or disease
significantly increases the risk of bacterial keratitis.
CD36 is a Class B scavenger receptor that is expressed on
multiple cell types, and recently it was found expressed con-
stitutively on the corneal epithelium.3–5 CD36 has multiple
ligands, including TSP1, oxidized LDLs, oxidized phospholip-
ids, and apoptotic cells.4 As a pleiotropic ligand, CD36 has
been implicated in multiple homeostatic and pathologic func-
tions, including angiogenesis, atherosclerosis, phagocytosis,
inflammation, lipid metabolism, and uptake of apoptotic cells.3
Recently Hardy and colleagues4 demonstrated that CD36 pre-
vents corneal neovascularization and helps maintain the avas-
cularity of the cornea. Furthermore they report that CD36/
mice develop spontaneous corneal neovascularization that in-
creases in severity with age.5 However, our data suggest that
the neovascularization is not spontaneous but is actually sec-
ondary to corneal defects that occur in the epithelium of aged
CD36/ mice.
Herein we report that CD36/ mice develop spontaneous
bacterial keratitis with age. Furthermore, the development of
bacterial keratits is secondary to the breakdown of two critical
components of the corneal epithelial barrier to infection: the
mucin layer and epithelial tight junctions. Mice are normally
highly resistant to bacterial keratitis, and this is the first report
of spontaneous keratitis developing in a mouse from resident
flora, highlighting a novel function for CD36 in maintaining the
corneal epithelial barrier to infection.
METHODS
Animals
Female C57BL/6 WT mice were purchased from the Jackson Labora-
tory (Bar Harbor, ME). The CD36/ (C57BL/6 background) mice were
originally received from Kathryn J. Moore (Massachusetts General
Hospital, Harvard Medical School, Boston, MA).6,7 The TSP1/ mice
(C57BL/6 background) were originally received from Jack Lawler
(BIDMC, Harvard Medical School, Boston, MA).8 All mice were bred
and maintained in a pathogen-free facility at Schepens Eye Research
Institute and provided with autoclaved tap water and autoclaved stan-
dard laboratory chow ad libitum. All animals were treated according to
the Association for Research in Vision and Ophthalmology Resolution
on the Use of Animals in Research. The Schepens IACUC committee
approved all procedures involving mice. Elke Cario provided enucle-
ated eyes from TLR2/ mice (Tlr2tm1Kir; F10 [C57BL6/J]) housed
under pathogen-free conditions at the Central Animal Facility of Uni-
versity Hospital of Essen. All animals were treated in compliance with
German law for use of live animals and approved by the Institutional
Animal Care and Use Committee at the University Hospital of Essen and
the responsible district government.
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Clinical Scoring
A one-time slit lamp examination was performed on each eye of every
mouse in our C57BL/6 WT (n  87), CD36/ (n  90), and TSP1/
(n  83) colonies. An additional subset of CD36/ mice (N  8) was
used to study disease progression and as such were monitored monthly
via slit lamp examinations for 13 months. After slit lamp examination,
the eyes were placed into three categories: (1) no corneal defect, clear
cornea; (2) mild corneal defect, mild corneal haze in which the iris is
still visible; and (3) severe corneal defect, corneal opacity and neovas-
cularization in which the iris is not visible. Enucleated eyes from
TLR2/ mice (N  8 mice) were examined ex vivo using a dissecting
microscope.
Histologic Analysis
Mice were euthanatized, and one group of eyes was enucleated, fixed
in 10% buffered formalin, embedded in paraffin, sectioned, and stained
with hematoxylin and eosin (H&E). A second group of eyes was
enucleated and snap-frozen (Tissue-Tek OCT compound; Sakura Fi-
netek, Torrance, CA). The frozen eyes were sectioned at 12-m incre-
ments and stored at 20°C until ready for use. Macrophages were
detected using a rat anti-mouse F4/80 antibody (Caltag, Burlingame,
CA). Neutrophils were detected using a rat anti-mouse Ly-6 (GR1)
antibody (Pharmingen, San Diego, CA) followed with a Cy3-conjugated
goat anti-rat IgG2b antibody (Jackson Laboratories, West Grove, PA).
Purified rat IgG2b was used as an isotope control (Pharmingen). A
cyanine nucleic acid stain (To-Pro-3; Molecular Probes, Eugene, OR)
was used to stain all cells. After immunostaining, tissue sections were
mounted (VectaShield Mounting Medium; Vector Laboratories, Burlin-
game, CA), protected with coverslips, and stored at 4°C until analyzed
by confocal microscopy. Immunostained tissue sections were analyzed
using a confocal laser scanning microscope (TCS 4D; Leica, Wetzler,
Germany). Gram staining was performed on paraffin-embedded tissues
using a Gram stain kit according to the manufacture’s protocol (Becton
Dickinson Co., Franklin Lakes, NJ).9
Bacterial Quantification and Identification
To quantify bacterial load in corneas from CD36/ mice with either
no corneal defects, mild defects, or severe defects, we enucleated the
eyes, and removed the corneas in a sterile environment. Each cornea
was minced with a sterile blade and transferred into an Eppendorf tube
containing 100 L sterile PBS. Cultures were plated on BHI agar plates
(Bacto Brain and Heart Infusion and Difco agar; Becton Dickinson,
Franklin Lakes, NJ) and grown at 37°C overnight. Colonies were
counted the following day. Five representative single colonies from
each BHI plate were streaked for identification (BBL Chromagar Ori-
entation agar plates; Becton Dickinson) and incubated at 37°C over-
night. The bacterial species were preliminarily identified based on
colony color (opaque pink) as described in the manufacturer’s guide-
lines (Becton Dickinson).
16S rRNA Sequencing and Analysis
For 16S rRNA gene sequence identification, single colonies from
each BHI agar plate (five representative colonies) were suspended
in 50 L sterile water, and a colony PCR was performed using 16S
rRNA gene eubacterial oligonucleotide primers 27F and 1429R
(Integrated DNA Technologies, Coralville, IA) as previously de-
scribed.10 PCR products were confirmed by electrophoresis
through a 1% agarose gel and visualized by ethidium bromide
staining. The 16S rRNA amplicons were sequenced by the DNA
Sequencing Center for Vision Research at the Ocular Molecular
Genetics Institute, Massachusetts Eye and Ear Infirmary (BigDye
Terminator v3.1 cycle sequencing Ready Reaction mixture; Applied
Biosystems, Foster City, CA). All 16S rRNA sequences were com-
piled using Basic Local Alignment Search Tool (BLAST) analysis.
Rose Bengal Staining
The corneal mucin layer was assessed in CD36/ and C57BL/6 WT
mice using a slightly modified Rose Bengal staining protocol that was
originally developed for rabbits.11 Briefly, Rose Bengal (Sigma-Aldrich,
St. Louis, MO) was diluted in sterile saline to make a 0.1% solution. One
drop of Rose Bengal was applied to the cornea of anesthetized mice.
After one minute of incubation, the drop of Rose Bengal was removed
by carefully placing a sponge at the limbus to absorb the excess dye
without damaging the corneal surface. The eyes were examined under
a slit lamp (Topcon Cooperation, Tokyo, Japan) using white light, and
representative pictures were taken.
LC-Biotin Staining
The integrity of the corneal epithelial tight junctions was assessed in
CD36/ and wild-type (WT)-C57BL/6 mice using the LC-biotin stain-
ing method as described previously.12,13 Briefly, 1 mg/mL stain (EZ-
Link-Sulfo-NHS-LC-Biotin; Pierce, Rockford, IL) was dissolved in a salt
solution (Hank’s Balanced Salt Solution; Lonza, Walkersville, MD) with
2 mM MgCl2 and 1 mM CaCl2.
13 At the time of euthanatization, one
drop of LC-biotin was applied to each eye. After 15 minutes, the eyes
were rinsed with PBS and enucleated. Eyes were frozen on dry ice
(Tissue-Tec O.C.T Compound; Sakura Finetek), and 8 m sections
were cut using a cryostat. The sections were fixed in acetone, blocked
with 1% BSA (bovine serum albumin, Sigma- Aldrich), and incubated
with fluorescein isothiocyanate (FITC)-conjugated streptavidin (1:50 in
1% BSA) and a nuclear dye (TO-PRO-3, 1:1000 in PBS; Invitrogen,
Carlsbad, CA) for 1 hour at room temperature. The stained sections
were mounted (Vectashield Mounting Medium for Fluorescein; Vector
Laboratories), and examined with a confocal laser-scanning micro-
scope (Leica Microsystems).
Staphylococcus aureus Binding Assay
To visualize bacterial binding to the cornea, a GFP- expressing strain of
S. aureus (ALC 1435) was used. S. aureus ALC 1435 is a derivative of
RN6390 containing the plasmid pALC1420 encoding GFP, whose con-
stitutive expression is controlled through the sar P1 promoter.14 Here
5 mL BHI (Bacto Brain and Heart Infusion; Becton Dickinson) was
inoculated with a single colony of ALC 1435 isolated from a BHI agar
plate and grown statically at 37°C overnight until the estimated density
of 1  108 colony forming units [CFUs]/mL was reached. After 17
hours of static growth the culture was diluted 1:25 in BHI and grown
shaking (200 rpm) until reaching an estimated density of 5  107
CFUs/mL or OD595  0.22  2. The bacteria were pelleted, washed
twice with PBS, and resuspended in 10 mL PBS. To assess bacterial
binding, freshly enucleated eyes were incubated with 1  108 CFUs of
the GFP-ALC1435 in a 48-well plate for 30 minutes at 37°C. After
incubation the eyes were washed twice with PBS. The corneas were
then excised in a sterile environment, mounted (Vectashield Mounting
Medium for Fluorescein; Vector Laboratories), and examined under a
confocal laser-scanning microscope (Leica).
Statistical Analysis
The appearance of corneal defects in CD36/ mice was statistically
analyzed using Fisher’s exact test. This test was also used to analyze the
bacterial load in corneas with and without severe defects. Significance
was determined at P  0.05. The relationship between age and the
development of corneal defects was analyzed using proportional odds
logistic regression (LogXact v.8; Cytel Inc., Cambridge, MA).
RESULTS
Age-Related Development of Corneal Defects in
CD36/ Knockout Mice
Similar to the corneal epithelium, a critical function of the
epidermis of the skin is to provide a barrier between the
IOVS, January 2011, Vol. 52, No. 1 Spontaneous Bacterial Keratitis in CD36 Knockout Mice 257
external environment and the organism. Furthermore, CD36
has been shown to play a critical role in both maintaining the
epidermal barrier and restoring the barrier after injury.15,16
Therefore, we tested the hypothesis that the spontaneous
development of corneal opacity and neovascualrization in
CD36/ mice5 is due to a breakdown in the epithelial barrier,
rendering the cornea more susceptible to infection.
To determine the frequency and severity of corneal defects
in CD36/ mice, we performed a slit lamp examination of
each mouse in our CD36/ (N  90) and WT-C57BL/6 (N 
87) colonies. The age of mice at the time of examination
ranged from 2 to 16 months in both colonies. After examina-
tion the eyes were placed into three categories: (1) no corneal
defect, clear cornea; (2) mild corneal defect, mild corneal haze
through which the iris is visible; and (3) severe corneal defect,
corneal opacity and neovascularization through which the iris
is not visible. All the WT-C57BL/6 mice, regardless of age,
presented with normal clear corneas (Figs. 1A and 1C). By
contrast, the CD36/ mice presented with mild corneal de-
fects as early as 2 months old at a frequency of 7% (2/28). The
frequency of mild corneal defects increased significantly with
age, and in 16-month-old CD36/ mice the frequency of mild
corneal defects was 60% (12/20) (Figs. 1A and 1B). The severe
corneal defects first appeared at 6 months of age and increased
in frequency to 40% (8/20) in 16-month-old CD36/ mice.
Moreover, monthly monitoring of a subset of CD36/ mice
revealed the development of mild defects always preceded the
development of severe defects (Fig. 1D). Overall, the fre-
quency and severity of mild and severe corneal defects ob-
served in CD36/mice increased with age, and by 16 months
100% of CD36/ mice displayed either mild or severe defects
(Figs. 1B and 1D). There was a statistically significant relation-
ship between increasing age and the presence of corneal de-
fects in CD36/ mice compared with controls as determined
by proportional odds logistic regression (beta  0.3652, P 
5.005  108). We conclude that CD36/ mice spontane-
ously develop corneal defects that increase in frequency and
severity with age.
Histologic Analysis of Corneal Defects in
CD36/ Mice
Histologic analysis and immunofluorescence was performed to
identify the histologic changes that coincide with the mild and
severe defects. H&E staining of clear corneas isolated from
young CD36/ mice revealed a normal corneal epithelium,
stroma, and endothelium (Figs. 2A and 2B). Mild corneal de-
fects coincided with the presence of disorganized apical epi-
thelial layers, thickened basement membrane, and an infiltrate
into the apical stroma just under the epithelial defect (Figs. 2A
and 2B). Severe defects coincided with the presence of signif-
icant epithelial damage and a massive inflammatory infiltrate
throughout the cornea (Figs. 2A and 2B). Interestingly, immu-
nofluorescence revealed an increased number of F4/80 macro-
phages in “clear” (no defects visible) corneas from young
CD36/ mice compared with WT-C57BL/6 mice (Fig. 2C).
The numbers of macrophages increased with the severity of
the defect and were localized to the site of the corneal defect.
By contrast, neutrophils were detected only in corneas with
severe defects (Fig. 2D). The histology of the severe corneal
defects is consistent with the histology observed in bacterial
keratitis.17,18 Therefore, the next series of studies were per-
formed to determine whether bacteria were present in the
corneas with severe lesions.
Bacterial Quantification
Bacterial quantification was performed to determine whether
the severe corneal defects coincided with bacterial keratitis.
Two methods were used to detect the presence of bacteria
within the corneal tissue: Gram stain and enumeration of
FIGURE 1. CD36/ mice spontaneously developed corneal defects that increase in frequency and severity with age. (A) Slit lamp pictures of
representative eyes from of CD36/ mice that display (1) no corneal defect, clear cornea; (2) mild corneal defect, mild corneal haze through
which the iris is visible; and (3) severe corneal defect, corneal opacity, and neovascularization through which the iris is not visible. (B) The
frequency of corneal defects in CD36/ mice (n  90). (C) Age-matched WT C57BL/6 mice served as a negative control (n  87). (D) Disease
progression was monitored monthly in a subset of CD36/mice (n 8). Asterisk indicates significant difference in the frequency of severe lesions
between 16-month-old CD36/ and WT-C57BL/6 mice (P  1.745  109) and was determined by Fisher’s exact test. Development of corneal
defects in CD36/ mice was age dependent as determined by proportional odds logistic regression (beta  0.3652, P  5.005  108).
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bacterial colonies from corneal tissue. Gram staining was per-
formed on CD36/ corneas with no defect, mild defects, and
severe defects (Fig. 3A). No bacteria were detected by Gram
stain in corneas with either no defects or mild defects. By
contrast, a large amount of Gram-positive bacteria (dark pur-
ple) were detected in severe corneal defects (Fig. 3A). Higher
magnification revealed individual cocci indicative of Gram-
positive bacteria. Bacteria present in the corneas of WT-
C57BL/6 and CD36/ mice with no defect, mild defect, or
severe defect were quantified by plate count. Bacterial quanti-
fication revealed large numbers of bacteria (1000 CFUs) in
75% of the CD36/ corneas with severe defects (Fig. 3B).
Moderate colonization (1000 CFUs) of 25% of CD36/ cor-
neas with severe defects as well as 25% of corneas with mild
defects was observed. There was a statistically significant dif-
ference in the frequency of corneas with a high bacterial load
in mice with severe lesions compared with either (1) wild-type
corneas or (2) corneas from young CD36/ mice with no
defects. (Fisher’s exact test, significance P  0.01). Represen-
tative colonies grown on BHI plates from corneas with severe
defects were cultured (BBL Chromagar orientation plates; Bec-
ton Dickinson) and produced opaque pink colonies, indicative
of Staphylococci (data not shown). In addition, 16s ribosomal
RNA sequencing and BLAST analysis in GenBank revealed a
99% homology to Staphylococcus xylosus, a commensal bac-
terium on the skin of humans and rodents (data not
shown)19,20.
Corneal Defects in TSP1/ and TLR2/ Mice
CD36 is a member of the class B scavenger receptor family
with multiple functions.3–5 Previous studies demonstrated
that CD36 inhibited neovascularization through the binding
of thrombospondin-1 (TSP1) and activation of anti-angio-
genic pathways.4 In addition, CD36 acts as a co-receptor for
TLR2 and is required for the internalization of S. aureus and
initiation of TLR2/6 signaling.7 Therefore, the development
of bacterial keratitis in CD36/ mice may be due to inhi-
bition of the TSP1 and/or TLR2 signaling pathway. To de-
termine whether corneal defects develop in CD36/ mice
that lack either TSP1 or TLR2, we examined the corneas of
TSP1/ and TLR2/ mice. Clinical examination and his-
tologic analysis revealed no corneal defects in TSP1/ or
TLR2/ mice up to 25 months of age (Table 1). In CD36/
mice, 38% (14/36) of the mice present with either a mild or
severe corneal defect by 11 months of age. By contrast, 0%
(0/43) of the TSP1/ mice displayed any corneal defects.
Furthermore, 100% (20/20) of the CD36/ mice present
with a mild or severe corneal defect by 16 months of age,
while 0% (0/8) of the TLR2/ mice present with any
corneal defects at 25 months of age. These results indicate
FIGURE 2. Histology of corneal de-
fects. Corneas were recovered from
mice with no defects, young CD36/
mice; mild defects; or severe defects.
(A,B) Corneas were fixed, paraffin em-
bedded, sectioned, and stained with
hematoxylin and eosin. (C) Corneas
were recovered from WT C57BL/6
mice or CD36/ mice with either no
defect, mild defect, or severe defects.
Corneas were snap frozen in OCT, sec-
tioned, and stained with either an iso-
type-matched control antibody or an
anti-F4/80 antibody (specific for mac-
rophages). (D) A similar set of corneal
sections were stained with either an
isotype-matched control antibody or
an anti-GR1 antibody (specific for neu-
trophils). All sections were stained
with a cyanine nucleic acid stain (blue)
to identify the cell nucleus. Immuno-
fluorescence was examined via confo-
cal microscopy. Ep, epithelium; S,
stroma; En, endothelium. Black ar-
rowheads identify a thickened base-
ment membrane. White arrowheads
identify a stromal infiltrate directly
under the mild corneal defect. White
arrows identify F4/80- and GR1-pos-
itive cells.
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that the spontaneous corneal defects that occur in CD36/
mice are independent of either TSP1 or TLR2 pathway.
Rose Bengal Staining in CD36/ Mice
The mucin layer is a major component of the ocular tear film
involved in preventing bacterial adherence to the cornea.1
Rose Bengal staining was used to determine whether the mild
and/or severe corneal defects coincided with a disruption in
the mucin layer.21 An intact mucin layer prevents positive Rose
Bengal staining in healthy eyes.22 By contrast, increased Rose
Bengal staining coincides with the disruption of the mucin
layer.23 Rose Bengal staining was negative in C57BL/6 WT eyes
and CD36/ corneas with no corneal defects (Fig. 4A). By
contrast, positive Rose Bengal staining was observed in
CD36/ corneas with either mild or severe defects. More-
over, the Rose Bengal staining was localized to the site of the
corneal defect, indicating that the mucin layer was only dis-
rupted at the site of the cornea defect (Fig. 4A).
LC-Biotin Staining in CD36/ Mice
Tight junctions located in the superficial layer of the corneal
epithelium act as a physical barrier to invading microorgan-
isms. The integrity of the epithelial tight junctions was tested
using a surface biotinylation (LC-biotin) method. This method
makes use of a small compound (EZ-Link Sulfo-NHS-LC-Biotin)
that normally does not penetrate the epithelial tight junc-
tions.12,24,25 Therefore, where the tight junctions are intact,
LC-biotin will biotinylate only the primary amines on the cor-
neal surface.12,13 By contrast, when the junctions are dis-
rupted, the compound passes between cells and stains the
stroma. The LC-biotin stain did not penetrate into the epithe-
lium in either normal WT C57BL/6 or clear CD36/ corneas,
indicating that the tight junctions are intact (Fig. 4B). By con-
trast, LC-biotin penetrated the epithelium in corneas of
CD36/ mice with either mild or severe defects. Interest-
ingly, the LC-biotin staining of the corneas with mild defects
reveals a detachment of the basal epithelium from the base-
ment membrane, suggesting a possible defect in cell adher-
ence. In conclusion, the LC-biotin staining in corneas with mild
defects demonstrates that, in the absence of CD36, a break-
down in the corneal barriers precedes the development of
bacterial keratitis.
Bacterial Binding to Corneas of CD36/ Mice
A critical step in the development of bacterial keratitis is the
binding of bacteria to the cornea. Under normal conditions, the
mucin barrier prevents bacterial binding, and the epithelial cell
tight junctions block bacteria from entering the cornea.26,27
Because these barriers are disrupted in CD36/ mice, we
next determined whether there is increased bacterial binding
to CD36/ corneas with mild defects. To analyze bacterial
binding, GFP-expressing S. aureus was incubated with corneas
with mild defects. Eyes from WT C57BL/6 mice and CD36/
FIGURE 3. Detecting bacteria in cor-
neal defects. Corneas were recov-
ered from WT-C57BL/6 mice or
CD36/ mice with either no de-
fects, mild defects, or severe defects.
(A) Corneal sections were stained
with a Gram stain. Gram-positive bac-
teria (dark purple) were detected in
corneas with severe lesions. Pictures
are representative of corneas from at
least three different mice. (B) The
bacterial load within individual cor-
neas was determined by homogeniz-
ing and culturing the corneal tissue
in BHI agar cultures. Bacterial colo-
nies were enumerated and the CFUs
for each cornea displayed [n  4
(C57BL/6), n 4 (no defect), n  8
(mild defect), n  4 (severe defect)].
Asterisk indicates significant increase
in bacterial load compared with all
other groups (Fisher’s exact test, P
0.01). Ep, epithelium; S, stroma; En,
endothelium. Black arrows identify
Gram-positive cocci.
TABLE 1. Corneal Defects in TSP1/, TLR2/, and CD36/ Mice
Severity of Defect*
Mouse Strain Age (mo)
No
Defect
Mild
Defect
Severe
Defect
CD36/ knockout* 2–6 31 2 1
8–11 22 11 3
16 0 12 8†
TSP1/ knockout‡ 2–6 40 0 0
8–11 43 0 0
TLR2/ knockout§ 19–25 8 0 0
* Data presented in Figure 1 and summarized here, n  90.
† Frequency of severe defects was compared using Fisher’s exact
test between (1) CD36/ mice 16 months old with TLR2/ mice
19–25 years old (P 6.4 107), and (2) CD36/mice 8–11 months
old with TSP1/ mice 8–11 months old (P  3.1  106).
‡ n  83.
§ n  8.
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mice with clear corneas were used as negative controls. As a
positive control, GFP-expressing S. aureus was added to WT-
C57BL/6 eyes with a corneal epithelium debridement wound
(data not shown). Confocal analysis revealed no bacterial bind-
ing to corneas of WT-C57BL/6 mice and CD36/ knockout
mice without any corneal defects (Fig. 5B). However, signifi-
cant binding of GFP-expressing S. aureus was observed in
CD36/ mice with mild defects, and the binding was con-
fined to the defect. These data indicate that the breakdown of
the barriers in the corneas with mild defects coincided with
increased bacterial binding. Moreover, this increased suscepti-
bility to bacterial binding in CD36/ precedes the develop-
ment of bacterial keratitis.
DISCUSSION
The cornea has multiple barriers that make it highly resistant to
bacterial keratitis. This resistance became apparent when re-
searchers in the past attempted to develop animal models of
bacterial keratitis. Several in vivo models were developed,
using rabbits,28 mice,29 and guinea pigs.30 However, each of
these models required either epithelial wounding28,29,31 or
intrastromal injection of bacteria32 to induce a successful in-
fection. Furthermore, although each of these techniques in-
duced bacterial keratitis, large nonphysiological amounts of
bacteria (1–4  108 CFUs) were also required in addition to a
corneal wound.20,29 The administration of a small amount of
bacteria to a corneal wound routinely failed to induce an
infection. Herein, we describe the first report of spontaneous
bacterial keratitis occurring in mice. Not surprisingly, keratitis
only developed after a breakdown in the epithelial barriers,
indicating the importance these physical defense mechanisms
in preventing infection.
Our study identifies CD36 as a critical component of the
corneal epithelial barrier to infection. In the absence of CD36,
the mucin layer and epithelial tight junctions break down with
age, allowing a member of the normal flora (S. xylosus) to bind
and penetrate the cornea resulting in spontaneous bacterial
keratitis. Although Staphylococcus is one of the most common
causes of bacterial keratitis in humans, it is considered an
opportunistic pathogen, inducing keratitis only when one or
more of the corneal barriers are breached.20 Our study identi-
fies a novel function for CD36 in maintaining the corneal
barriers to infection and preventing bacterial keratitis induced
by normal flora. Moreover, this novel function of CD36 is
independent of TSP1 and TLR2, because TSP1/ and TLR2/
mice failed to develop spontaneous keratitis.
CD36 is a member of the class B scavenger receptor family
with multiple functions. Beutler and colleagues33 were the first
to identify CD36 as a receptor of microbial diacylglycerides.
Moreover, they demonstrated that “oblivious” mice expressing
a mutant form of CD36 were unable to clear an intradermal
and/or intravenous S. aureus inoculum.33 This inability to clear
a Staphylococcus inoculation coincided with reduced macro-
phage function as determined by TNF production. Stuart and
colleagues7 demonstrated that induction of the innate immune
response to S. aureus requires CD36-mediated phagocytosis,
which triggers TLR2/6 signaling. The function of CD36 is
analagous to the LPS receptor, CD14, which clusters the LPS on
the cell surface where it engages with TLR2/6.7 Similarly, CD36
recognizes S. aureus and its cell wall component LTA and
clusters LTA at the cell surface, where it engages with TLR2/6.
Unlike CD14, however, CD36 can also phagocytose S. aureus
and LTA, concentrating them in the endosome where they
again engage TLR2/6. In the absence of CD36, macrophages
FIGURE 4. The epithelial barrier
function in the corneas of CD36/
mice. (A) Rose Bengal staining was
performed on WT-C57BL/6 mice and
CD36/ mice with different de-
fects. Rose Bengal stains positive
(pink) for disrupted mucin layers.
(B) Epithelial tight junctions were
examined with LC-biotin. Intact epi-
thelial tight junctions prevent LC-bi-
otin from penetrating the cornea and
staining the stroma (WT-C567BL/6
and CD36/ mice with no defect).
Disrupted epithelial tight junctions
allow LC-biotin to penetrate and
stain the stroma (CD36/mice with
mild and severe defects). All sections
were counterstained with a cyanine
nucleic acid stain (blue nuclei) and
analyzed via confocal microscopy.
Pictures are representative of five
mice per group. Ep, epithelium; S,
stroma; En, endothelium. Black arrows identify the positive Rose Bengal staining in CD36/ corneas with mild and severe defects. Asterisks
identify the LC-biotin (green) sitting on top of an intact epithelial barrier in WT-C57BL/6 and young CD36/ mice with no defect. White arrow
identifies epithelial detachment from the basement membrane.
FIGURE 5. Bacterial binding to corneal defects. (A) Slit lamp pictures
of eyes of WT-C57BL/6 mice and CD36/mice without and with mild
corneal defects. (B) The corneas displayed were recovered and incu-
bated in vivo with GFP-expressing S. aureus. Corneas were then
washed and examined by confocal microscopy for fluorescent bacte-
ria. Images are representative of at least three different mice per group.
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display a reduced ability to phagocytose bacteria, resulting in a
failure to activate the TLR2 signaling pathway.7 Therefore,
knocking out either CD36 or TLR2 resulted in a significantly
reduced protective innate immune response to an intravenous
challenge of S. aureus.
By contrast, the primary function of CD36 in the cornea
appears to be maintaining the physical barriers that prevent
bacterial binding. Intravenous injection of 107 CFUs of S.
aureus resulted in the death of 50% of CD36/ mice com-
pared with 0% of WT mice.7 However, we demonstrated that
young CD36/ mice (without any cornea defect) show no
increased susceptibility to S. aureus–induced keratitis when as
much as 108 CFUs of S. aureuswas added to an intact cornea.
Only after the development of the cornea defects did CD36/
mice display increased binding of bacteria at the site of the
defect. Moreover, TLR2/ mice did not develop either cor-
neal defects or spontaneous bacterial keratitis, indicating the
corneal pathology observed in CD36/ mice was due to the
role of CD36 in barrier function and not innate immunity. In
agreement with our study, Beutler and colleagues33 reported in
supplementary data that aged “oblivious” mice (that had not
received a bacterial inoculation) developed spontaneous en-
dophthalmitis. As endophthalmitis was not the focus of their
study, these investigators examined only a small number of
aged “oblivious” mice and did not examine the corneas of
these mice at an earlier stage of their infection (BRK, personal
communication with Bruce Beutler, 2006). Therefore, they
could not rule out a bacterial keratitis as the initial infection in
the eye. Taken together with our current studies, we propose
the endophthalmitis reported by Beutler and colleagues33 was
actually secondary to an initial bacterial keratitis caused by a
breakdown in the cornea allowing the bacteria to adhere to the
corneal surface.
Hardy and colleagues4 reported that an additional func-
tion of CD36 in the cornea was to maintain the avascularity
of the cornea. In a mouse model of inflammatory corneal
neovascularization, they demonstrated that CD36 inhibits
corneal neovascularization directly by inhibiting vessel out-
growth and indirectly by inhibiting macrophage-derived
VEGF-A expression.4 The authors went on to demonstrate
that CD36/ mice developed age-dependent corneal neovas-
cularization accompanied by increased expression of angio-
genic factors and inflammation.5 However, the cause of inflam-
mation in these older mice was unclear. Interestingly, we
demonstrate that before the development of neovasculariza-
tion, CD36/ mice develop a mild corneal defect that is
characterized by a breakdown in the mucin layer, a loss of
epithelial tight junctions, and a mild macrophage infiltration
into the stroma underlying the epithelial defect. Furthermore,
in vitro, we observed increased bacterial binding to the area
within the mild defect. Together, this suggests that the inflam-
mation and neovascularization observed by Hardy and col-
leagues is secondary to the breakdown of the corneal epithe-
lium and subsequent binding of normal flora.
Strict regulation of cell migration and adhesion is critical in
the homeostasis and wound repair of the corneal epithelium.
Several studies implicate CD36 in both cell adhesion and mi-
gration through interactions with actin, collagen, throm-
bospondin, and 31 and 61 integrins.34–38 Interestingly,
collagen and thrombospondin are major components of the
corneal epithelial basement membrane,39 while both 31 and
61 integrins are constitutively expressed in the basal epithe-
lium of the cornea where they mediate cell attachment to
matrix proteins in the basement membrane.40 Cellular migra-
tion is a complex process involving cell-to-matrix and cell-to-
cell adhesion and in the cornea in particular, the epithelium
must move as an intact sheet to maintain the barrier function.41
Taken together, these data suggest a novel function for CD36
in maintaining the structural integrity of the corneal epithelial
cell sheet as the cells continually migrate to replace the outer-
most shed layer. In addition, attachment to the basement mem-
brane is critical for the survival of adherent cells and epithelial
cells that detach from their underlying basement membrane
undergo apoptosis.42–44 The LC-biotin staining of our
CD36/ corneas with mild defects reveal a detachment of the
basal epithelium from the basement membrane coinciding
with the loss of tight junctions, suggesting a defect in cell
adhesion may underlie the formation of the mild corneal de-
fects. However, the development of the mild defect also coin-
cides with a mild infiltrate of macrophages into the underlying
stroma. Infiltrating macrophages have the ability to secrete a
variety of matrix metalloproteinases (MMPs) that digest extra-
cellular matrix and integrins. In particular MMP2 and MMP9 are
known to cleave specifically type 4 collagen, which is a major
structural component of the basement membrane.45,46 There-
fore, we cannot rule out that an early infiltration of macro-
phages secreting MMPs does not contribute to the detachment
of the corneal epithelium and loss of epithelial tight junctions.
In vitro experiments are currently underway to determine
whether corneal epithelial cells that lack CD36 exhibit defec-
tive adhesion and migration properties.
Interestingly, although CD36/ mice lack CD36 from
birth, development of the corneal defects and subsequent
spontaneous keratitis occurs only in aged mice. This suggests
that early in life other factors and/or pathways compensate for
the loss of CD36. However, there are numerous age-related
changes that occur in the cornea, resulting in increased cell
senescence, increased epithelial permeability, decreased ex-
pression of adhesion molecules, and diminished epithelial ad-
hesion to the basal lamina.47 More important, we predict age-
related changes in the cornea coincide with decreased
efficiency in compensatory mechanisms. For these reasons we
believe the corneal pathogenesis associated with CD36 defi-
ciency becomes apparent only with age and occurs in the
central cornea where exposure to environmental insults is the
greatest.
In conclusion, our data suggest a novel function for CD36 in
the maintenance of the corneal epithelial barriers to infection.
In the absence of CD36, the epithelial barrier and mucin layer
are disrupted, allowing the normal corneal flora to bind and
promoting the development of bacterial keratitis. This is the
first report of spontaneous bacterial keratitis in a mouse.
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